{"title":"对医学实验室质量控制的应用及跟踪的建议。","authors":"Jean-Marc Giannoli, Stéphanie Albarede, Thierry Avellan, Jean-Pierre Bouilloux, Régine Cartier, Richard Cohen, Nathalie Colard, Luc Essemilaire, Jean-Louis Galinier, Mathieu Kuentz, Mickaël Paris, Henri Portugal, Florian Scherrer, Jean-Pascal Siest, Anne Vassault, Jean-Michel Vialle","doi":"10.11613/BM.2021.020501","DOIUrl":null,"url":null,"abstract":"<p><p>This is a translation of the paper \"Recommendations for the application and follow-up of quality controls in medical biology laboratories\" published in French in the journal Annales de Biologie Clinique (Recommandations pour la mise en place et le suivi des contrôles de qualité dans les laboratoires de biologie médicale. Ann Biol Clin (Paris). 2019;77:577-97.). The recommendations proposed in this document are the result of work conducted jointly by the Network of Accredited Medical Laboratories (LABAC), the French Society of Medical Biology (SFBC) and the Federation of Associations for External Quality Assessment (FAEEQ). The different steps of the implementation of quality controls, based on a risk analysis, are described. The changes of reagent or internal quality control (IQC) materials batches, the action to be taken in case of non-conform IQC results, the choice of external quality assessment (EQA) scheme and interpretation of their results as well as the new issue of analyses performed on several automatic systems available in the same laboratory are discussed. Finally, the concept of measurement uncertainty, the robustness of the methods as well as the specificities of near-patient testing and rapid tests are described. These recommendations cannot apply for all cases we can find in medical laboratories. The implementation of an objective alternative strategy, supported with documented evidence, might be equally considered.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"020501"},"PeriodicalIF":3.8000,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047787/pdf/","citationCount":"2","resultStr":"{\"title\":\"Recommendations for the application and follow-up of quality controls in medical laboratories.\",\"authors\":\"Jean-Marc Giannoli, Stéphanie Albarede, Thierry Avellan, Jean-Pierre Bouilloux, Régine Cartier, Richard Cohen, Nathalie Colard, Luc Essemilaire, Jean-Louis Galinier, Mathieu Kuentz, Mickaël Paris, Henri Portugal, Florian Scherrer, Jean-Pascal Siest, Anne Vassault, Jean-Michel Vialle\",\"doi\":\"10.11613/BM.2021.020501\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This is a translation of the paper \\\"Recommendations for the application and follow-up of quality controls in medical biology laboratories\\\" published in French in the journal Annales de Biologie Clinique (Recommandations pour la mise en place et le suivi des contrôles de qualité dans les laboratoires de biologie médicale. Ann Biol Clin (Paris). 2019;77:577-97.). The recommendations proposed in this document are the result of work conducted jointly by the Network of Accredited Medical Laboratories (LABAC), the French Society of Medical Biology (SFBC) and the Federation of Associations for External Quality Assessment (FAEEQ). The different steps of the implementation of quality controls, based on a risk analysis, are described. The changes of reagent or internal quality control (IQC) materials batches, the action to be taken in case of non-conform IQC results, the choice of external quality assessment (EQA) scheme and interpretation of their results as well as the new issue of analyses performed on several automatic systems available in the same laboratory are discussed. Finally, the concept of measurement uncertainty, the robustness of the methods as well as the specificities of near-patient testing and rapid tests are described. These recommendations cannot apply for all cases we can find in medical laboratories. The implementation of an objective alternative strategy, supported with documented evidence, might be equally considered.</p>\",\"PeriodicalId\":9021,\"journal\":{\"name\":\"Biochemia Medica\",\"volume\":\"31 2\",\"pages\":\"020501\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2021-06-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047787/pdf/\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemia Medica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.11613/BM.2021.020501\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/4/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemia Medica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.11613/BM.2021.020501","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/4/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 2
摘要
本文是法语版《医学生物学实验室质量控制的应用和后续建议》的翻译,发表在《临床生物学年鉴》(Recommendations pour la mise en place et le suivi des contrôles de qualit dans les laboratoires de Biologie m dicale》杂志上。Ann Biol诊所(巴黎)。2019; 77:577 - 97)。本文件中提出的建议是由认可医学实验室网络(LABAC)、法国医学生物学学会(SFBC)和外部质量评估协会联合会(FAEEQ)共同开展的工作的结果。基于风险分析,描述了实施质量控制的不同步骤。讨论了试剂或内部质量控制(IQC)材料批次的变化,IQC结果不符合时应采取的措施,外部质量评估(EQA)方案的选择及其结果的解释,以及在同一实验室可用的多个自动系统上进行分析的新问题。最后,介绍了测量不确定度的概念、方法的鲁棒性以及近病人检测和快速检测的特殊性。这些建议并不适用于我们在医学实验室中发现的所有病例。同样可以考虑执行一项有文件证据支持的客观替代战略。
Recommendations for the application and follow-up of quality controls in medical laboratories.
This is a translation of the paper "Recommendations for the application and follow-up of quality controls in medical biology laboratories" published in French in the journal Annales de Biologie Clinique (Recommandations pour la mise en place et le suivi des contrôles de qualité dans les laboratoires de biologie médicale. Ann Biol Clin (Paris). 2019;77:577-97.). The recommendations proposed in this document are the result of work conducted jointly by the Network of Accredited Medical Laboratories (LABAC), the French Society of Medical Biology (SFBC) and the Federation of Associations for External Quality Assessment (FAEEQ). The different steps of the implementation of quality controls, based on a risk analysis, are described. The changes of reagent or internal quality control (IQC) materials batches, the action to be taken in case of non-conform IQC results, the choice of external quality assessment (EQA) scheme and interpretation of their results as well as the new issue of analyses performed on several automatic systems available in the same laboratory are discussed. Finally, the concept of measurement uncertainty, the robustness of the methods as well as the specificities of near-patient testing and rapid tests are described. These recommendations cannot apply for all cases we can find in medical laboratories. The implementation of an objective alternative strategy, supported with documented evidence, might be equally considered.
期刊介绍:
Biochemia Medica is the official peer-reviewed journal of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Journal provides a wide coverage of research in all aspects of clinical chemistry and laboratory medicine. Following categories fit into the scope of the Journal: general clinical chemistry, haematology and haemostasis, molecular diagnostics and endocrinology. Development, validation and verification of analytical techniques and methods applicable to clinical chemistry and laboratory medicine are welcome as well as studies dealing with laboratory organization, automation and quality control. Journal publishes on a regular basis educative preanalytical case reports (Preanalytical mysteries), articles dealing with applied biostatistics (Lessons in biostatistics) and research integrity (Research integrity corner).